Preliminary experiments show conolidine may well inhibit certain ion channels, reducing neuronal excitability and limiting discomfort signals. This mechanism is especially related in neuropathic soreness, where irregular signaling triggers persistent soreness. On top of that, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort notion. Computa... https://erice162vnd8.corpfinwiki.com/user